📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Adheron Therapeutics

1.1 - Company Overview

Adheron Therapeutics Logo

Adheron Therapeutics

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biotechnology therapeutics that disrupt cell adhesion to treat a variety of diseases, based on pioneering work from Dr. Michael Brenner’s lab at Brigham and Women’s Hospital and Harvard Medical School, including work around Cadherin-11 (Cad-11), a cellular adhesive.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Adheron Therapeutics

Achilles Therapeutics Logo

Achilles Therapeutics

HQ: United Kingdom Website
  • Description: Provider of patient-specific cancer immunotherapies that harness the immune system to target truncal tumor neoantigens. Offers PELEUS, an AI-powered bioinformatics platform to identify clonal neoantigens; VELOS, a manufacturing process to create clonal neoantigen-reactive T cell (cNeT) products; and cNeT cell therapies targeting multiple clonal neoantigens to treat cancer while sparing healthy tissue.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Achilles Therapeutics company profile →
MacroGenics Logo

MacroGenics

HQ: United States Website
  • Description: Provider of immunotherapeutics, including antibody-drug conjugates and DART bispecifics targeting B7-H3, PD-1×CTLA-4 and CD123, to treat metastatic castration-resistant prostate cancer, advanced solid tumors, CD123-positive neoplasms (AML, MDS) and multiple cancers; programs include vobramitamab duocarmazine, lorigerlimab, MGD024, MGC026, MGC028 and enoblituzumab.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full MacroGenics company profile →
Apeiron Biologics Logo

Apeiron Biologics

HQ: Austria Website
  • Description: Provider of discovery and development of novel cancer immunotherapies, with products including Qarziba (cancer immunotherapy, licensed to EUSAPharma), APN401 (first-in-class autologous cell therapy inhibiting the immune checkpoint Cbl-b using RNAi to treat solid tumors), and APN01 (inhaled treatment in clinical trials targeting SARS-CoV-2 in the respiratory tract).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Apeiron Biologics company profile →
Vivace Therapeutics Logo

Vivace Therapeutics

HQ: United States Website
  • Description: Provider of small-molecule YAP-TEAD transcription activity inhibitors targeting the Hippo-YAP pathway for cancer treatment, with a focus on Hippo-YAP pathway research to discover and develop cancer therapeutics.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Vivace Therapeutics company profile →
SuppreMol Logo

SuppreMol

HQ: Germany Website
  • Description: Provider of biotechnology therapies pioneering a novel approach to treat autoimmune diseases, aiming to cure these disorders rather than merely manage symptoms; privately held.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full SuppreMol company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Adheron Therapeutics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Adheron Therapeutics

2.2 - Growth funds investing in similar companies to Adheron Therapeutics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Adheron Therapeutics

4.2 - Public trading comparable groups for Adheron Therapeutics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Adheron Therapeutics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Adheron Therapeutics

What does Adheron Therapeutics do?

Adheron Therapeutics is a provider of biotechnology therapeutics that disrupt cell adhesion to treat a variety of diseases, based on pioneering work from Dr. Michael Brenner’s lab at Brigham and Women’s Hospital and Harvard Medical School, including work around Cadherin-11 (Cad-11), a cellular adhesive.

Who are Adheron Therapeutics's competitors?

Adheron Therapeutics's competitors and similar companies include Achilles Therapeutics, MacroGenics, Apeiron Biologics, Vivace Therapeutics, and SuppreMol.

Where is Adheron Therapeutics headquartered?

Adheron Therapeutics is headquartered in United States.

How many employees does Adheron Therapeutics have?

Adheron Therapeutics has 1,000 employees 🔒.

When was Adheron Therapeutics founded?

Adheron Therapeutics was founded in 2010 🔒.

What sector and industry vertical is Adheron Therapeutics in?

Adheron Therapeutics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Adheron Therapeutics

Who are the top strategic acquirers in Adheron Therapeutics's sector and industry

Top strategic M&A buyers and acquirers in Adheron Therapeutics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Adheron Therapeutics?

Top strategic M&A buyers groups and sectors for Adheron Therapeutics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Adheron Therapeutics's sector and industry vertical

Which are the top PE firms investing in Adheron Therapeutics's sector and industry vertical?

Top PE firms investing in Adheron Therapeutics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Adheron Therapeutics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Adheron Therapeutics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Adheron Therapeutics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Adheron Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Adheron Therapeutics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Adheron Therapeutics?

The key public trading comparables and valuation benchmarks for Adheron Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Adheron Therapeutics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Adheron Therapeutics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Adheron Therapeutics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Adheron Therapeutics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Adheron Therapeutics's' sector and industry vertical?

Access recent funding rounds and capital raises in Adheron Therapeutics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Adheron Therapeutics